Struggling to find Invokamet at your pharmacy? Learn why this diabetes medication can be hard to locate in 2026 and what you can do to fill your prescription.
You go to pick up your Invokamet prescription and hear the dreaded words: "We don't have it in stock." For people managing type 2 diabetes, this isn't just an inconvenience — it's a real problem. Missing doses of your diabetes medication can throw your blood sugar out of control and put your health at risk.
If you've been struggling to find Invokamet at your local pharmacy, this article will help you understand why it's happening and, more importantly, what you can do about it.
Invokamet is a brand-name prescription medication that combines two diabetes drugs into one tablet: Canagliflozin (an SGLT2 inhibitor) and Metformin (a biguanide). It's manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.
Doctors prescribe Invokamet to help adults with type 2 diabetes control their blood sugar levels when diet and exercise alone aren't enough. The two active ingredients work through different mechanisms — Canagliflozin helps your kidneys remove excess sugar through your urine, while Metformin reduces the amount of sugar your liver produces and helps your body use insulin more effectively.
Invokamet comes in immediate-release tablets (taken twice daily) and an extended-release version called Invokamet XR (taken once daily). Both versions are available in several strengths, including 50/500 mg, 50/1000 mg, 150/500 mg, and 150/1000 mg.
To learn more about how this medication works, check out our guide on how Invokamet works.
There are several reasons why you might have trouble finding Invokamet at your pharmacy in 2026. Here are the most common ones:
Invokamet is still under patent protection, with generic versions not expected until around 2029. Because there's no generic alternative for the combination tablet, there's only one manufacturer — Janssen — producing it. This means supply depends entirely on one company's production capacity.
Unlike widely available generic Metformin, which costs as little as $4 per month and is stocked by virtually every pharmacy, a brand-name combination product like Invokamet may not be something every pharmacy keeps on their shelves.
Brand-name diabetes medications can cost pharmacies $575 to $800 per box to stock. Smaller pharmacies and even some chain locations may not keep Invokamet in their regular inventory if they don't have enough patients who use it. They may need to special-order it, which can take a few days.
Many insurance plans classify Invokamet as a non-preferred brand, meaning they may require prior authorization or step therapy before they'll cover it. Some plans prefer other SGLT2 inhibitor/Metformin combinations like Synjardy or Xigduo XR. When a pharmacy sees that insurance won't cover it without extra steps, the prescription can get stuck in limbo — and the pharmacy may not stock a medication they rarely dispense.
Pharmaceutical supply chains are complex, and brand-name medications can experience intermittent distribution issues. While Invokamet is not currently on the FDA's official drug shortage list, individual pharmacies may experience temporary gaps in their supply, especially for less commonly prescribed strengths like 150/500 mg.
Don't panic — there are practical steps you can take to locate your medication:
Instead of calling pharmacy after pharmacy, use Medfinder to quickly find which pharmacies near you have Invokamet in stock. It saves time and frustration, especially when you need your medication right away.
Independent pharmacies are often more willing to special-order brand-name medications and may have more flexibility in their ordering. They can sometimes get Invokamet within 24 to 48 hours. Read more tips in our guide on how to find Invokamet in stock near you.
If you consistently can't find Invokamet, your doctor might consider switching you to a different SGLT2 inhibitor/Metformin combination like Synjardy (Empagliflozin/Metformin) or Xigduo XR (Dapagliflozin/Metformin). Another option is taking the two components separately — brand-name Invokana (Canagliflozin) plus generic Metformin. Learn about your options in our alternatives guide.
Janssen's CarePath Savings Program may help commercially insured patients pay $0 per month for Invokamet. Having a copay card can sometimes make pharmacies more willing to stock the medication because they know patients can afford it. For more savings strategies, check out our article on how to save money on Invokamet.
Request refills at least a week before you run out. This gives your pharmacy time to order it if it's not in stock. Setting up automatic refill reminders through your pharmacy's app can help you stay ahead of potential delays.
Finding Invokamet can be challenging, but it's not impossible. The main barriers — limited manufacturing, pharmacy stocking decisions, and insurance hurdles — are all things you can work around with the right approach.
If you're tired of the pharmacy runaround, Medfinder can help you locate Invokamet in stock near you. And if the cost is a concern, explore manufacturer savings programs and patient assistance options — you may be able to get your medication for much less than you think.
Your blood sugar management is too important to leave to chance. Stay proactive, plan ahead, and don't hesitate to ask your healthcare provider for help navigating availability issues.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
